GleamWall
中文EN

AVAI AVAI BIO, INC.

Services-Computer Processing & Data Preparation · OTC · SEC CIK 1740797 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-3,582.8%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-239.1%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets405.2%
Debt / equity—
Current ratio0.04x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.55x
Accruals ratio-107.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31
Income statement
Revenue——
R&D expense$15,000—
SG&A expense$792,265$762,478
Operating income-$1.75M-$1.14M
Net income-$1.75M-$1.14M
EBITDA-$1.72M-$1.07M
EPS (basic)-0.01-0.01
EPS (diluted)——
Balance sheet
Cash & equivalents$23,145$81,053
Current assets$89,340$93,133
PP&E, net$1,500—
Intangibles$105,542$131,612
Total assets$572,696$224,745
Current liabilities$3.39M$1.79M
Short-term debt$24,918$30,000
Total liabilities$3.39M$1.79M
Shareholders' equity-$2.82M-$1.56M
Shares outstanding153.21M137.36M
Cash flow statement
Operating cash flow-$1.01M-$1.16M
Financing cash flow$951,936$1.24M
Depreciation & amortization$26,070$74,320

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.